Okay, let's tackle this question about bradykinin. The question is asking which of the following is not caused by bradykinin. First, I need to recall what bradykinin does. Bradykinin is a peptide involved in inflammation. It's part of the kinin system, right? So, its main effects are related to vasodilation, increasing vascular permeability, causing pain, and maybe bronchoconstriction. Let me think.

The options aren't provided, but common distractors in such questions might include things like vasoconstriction, decreased pain sensitivity, or bronchodilation. Since the question is about what bradykinin does NOT cause, the correct answer would be the opposite of its known effects. For example, if an option says "vasoconstriction," that's the exception because bradykinin causes vasodilation. Similarly, if an option mentions decreasing vascular permeability, that's incorrect because bradykinin increases it.

Wait, bradykinin also acts on B2 receptors. Activation of these receptors leads to nitric oxide and prostacyclin release, which cause smooth muscle relaxation. So, bronchoconstriction would be a possible effect if the smooth muscle is in the bronchi, but in reality, bradykinin might have a more complex effect depending on the tissue. Hmm, maybe bronchodilation isn't a typical effect. Alternatively, maybe the question is about vasoconstriction versus vasodilation.

Let me structure this. The core concept is bradykinin's role in inflammation via B2 receptors. Correct answer would be an effect opposite to its known actions. The incorrect options would be things like vasoconstriction (since it causes vasodilation), decreased pain (it causes pain), or decreased vascular permeability (it increases it). So the exception would be one of these.

For the clinical pearl, maybe a mnemonic like "Brady brings the pain, leaks the vessels, and dilates the blood flow." Also, remember that ACE inhibitors cause bradykinin accumulation, leading to cough due to increased bradykinin effects.

So, putting it all together: the correct answer is the one that contradicts bradykinin's known effects. If an option says vasoconstriction, that's the exception. Let's say the options are A. Vasodilation, B. Vasoconstriction, C. Pain, D. Increased vascular permeability. Then B is the correct answer.

Need to make sure each section is covered. Core concept is the kinin system and B2 receptors. Why correct answer is right: bradykinin acts via B2 receptors, leading to NO and PGI2, causing vasodilation, etc. Why wrong options are wrong: vasoconstriction is opposite, pain is correct, increased permeability is correct. Clinical pearl: ACE inhibitors cause bradykinin accumulation, leading to cough and angioedema.

**Core Concept**
Bradykinin is a proinflammatory peptide of the kinin system, acting via B2 receptors to mediate vasodilation, increased vascular permeability, pain, and bronchoconstriction. Its effects are counteracted by angiotensin-converting enzyme (ACE), making it a key player in angioedema and cough associated with ACE inhibitors.

**Why the Correct Answer is Right

✓ Correct Answer: D. Opsonisation